A Double-blind, Randomized, Sham#procedure#controlled, Parallel-group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (CEP#41750) in Patients with Chronic Heart Failure Due to Left Ventricular Systolic Dysfunction of Either Ischemic
Sponsoring Agencies:
INVENTIV CLINICAL LLC, MESOBLAST INC, NOVARTIS PHARMA AG
